Disclosed positions

Estimated from their latest filings — positions may have changed since

$6.25M

combined est. value

Stock	Shares	Price	Value	Weight	As of
RGENREPLIGEN CORP	40,051	$140.72	$5.64M	90%	2026-05-14
STIMNeuronetics, Inc.	371,816	$1.66	$617.2K	10%	2025-10-20

RGEN

REPLIGEN CORP

$5.64M

40,051 sh

STIM

Neuronetics, Inc.

$617.2K

371,816 sh

All filings on record

Every Form 4 transaction we track for this filer

all 4buys 0sells 0

Stock	Transaction	Date	~6mo later
RGENREPLIGEN CORP	Grant — · 995 sh	2026-05-14	—
RGENREPLIGEN CORP	Exercise $87.9K · 3,366 sh	2025-12-16	—
STIMNeuronetics, Inc.	Grant — · 7,554 sh	2025-10-20	—
STIMNeuronetics, Inc.	Grant — · 30,000 sh	2025-05-22	—

RGENGrant

2026-05-14 · REPLIGEN CORP

995

—

RGENExercise

2025-12-16 · REPLIGEN CORP

$87.9K

—

STIMGrant

2025-10-20 · Neuronetics, Inc.

7,554

—

STIMGrant

2025-05-22 · Neuronetics, Inc.

30,000

—

Outcomes measure each disclosed buy against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.